TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House October 2, 1987